Question 1

Does Lazard Asset Management own IOVA stock?

Accepted Answer

No. Lazard Asset Management exited its IOVA (Iovance Biotherapeutics) position in Q3 2025. Its Q2 2025 13F listed 7,744 shares worth $13,000.

Question 2

How many shares of IOVA does Lazard Asset Management own?

Accepted Answer

None since Q3 2025, when Lazard Asset Management exited the position. Its Q2 2025 13F listed 7,744 shares worth $13,000.

Question 3

What is Lazard Asset Management's IOVA position worth?

Accepted Answer

Lazard Asset Management's IOVA position was worth $13,000 in its Q2 2025 13F, before the exit in Q3 2025.

Question 4

Is Lazard Asset Management buying or selling IOVA?

Accepted Answer

In Q3 2025, Lazard Asset Management exited its entire IOVA position.

Question 5

When did Lazard Asset Management first buy IOVA?

Accepted Answer

Lazard Asset Management first reported IOVA in its Q4 2020 13F and listed it in 19 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$2.17	0
2025-Q2	Decreased	7,744	-64.3%	$13,000	0.0%	$1.72	0
2025-Q1	Increased	21,690	+333x	$72,000	0.0%	$3.33	34
2024-Q4	Unchanged	65	0.0%	$0	0.0%	$7.40	0
2024-Q3	Decreased	65	-71.2%	$0	0.0%	$9.39	0